| 摘要 |
The proliposome powder comprises discrete particles each comprising in a single phase; (1) a biologically active component selected from antiinflammatory and bronchorelaxing drugs, antihistamines, cyclooxygenase inhibitors, leukotriene synthesis inhibitors, leukotriene antagonists, phospholipase-A2 inhibitors, platelet aggregating factor antagonists, antiarrhythmic drugs, tranquilisers, cardiac glycosides, hormones, anti-hypertensive drugs, antidiabetic, antiparisitic and anticancer drugs, sedatives, analgesic drugs, antibiotics, antirheumatic drugs, immunotherapies, antifungal drugs, antihypotension drugs, vaccines, antiviral drugs, proteins, peptides and vitamins; (2) a stabilising proportion of tocopherol; and (3) a lipid or mixture of lipids having a phase transition temperature of below 37°C.
|
